Casdin Capital
North America, New York, United States, New York
Description
Casdin Capital is a fundamental research investment firm focused on the life sciences and healthcare industry.
Investor Profile
Casdin Capital has made 218 investments, with 8 in the past 12 months and 16% as lead.
Stage Focus
- Series B (31%)
- Series A (21%)
- Series C (15%)
- Series Unknown (9%)
- Post Ipo Equity (8%)
- Series D (6%)
- Series E (4%)
- Seed (3%)
- Series F (1%)
- Debt Financing (1%)
Country Focus
- United States (88%)
- France (3%)
- United Kingdom (2%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Canada (1%)
- Switzerland (1%)
- China (1%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
- The Netherlands (1%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Life Science
- Genetics
- Pharmaceutical
- Health Diagnostics
- Biopharma
- Software
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
